Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy. 2023

Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0329, Japan. mayu@med.kitasato-u.ac.jp.

Native T1 mapping is used to assess myocardial tissue characteristics without gadolinium contrast agents. The focal T1 high-intensity region can indicate myocardial alterations. This study aimed to identify the association between the native T1 mapping including the native T1 high region and left ventricular ejection fraction (LVEF) recovery in patients with dilated cardiomyopathy (DCM). Patients with newly diagnosed DCM (LVEF of < 45%) who underwent cardiac magnetic resonance imaging with native T1 mapping were included in the analysis. Native T1 high region was defined as a signal intensity of > 5 SD in the remote myocardium. Recovered EF was defined as a follow-up LVEF of ≥ 45% and an LVEF increase of ≥ 10% after 2 years from baseline. Seventy-one patients met the inclusion criteria for this study. Forty-four patients (61.9%) achieved recovered EF. Logistic regression analysis showed that the native T1 value (OR: 0.98; 95% CI: 0.96-0.99; P = 0.014) and the native T1 high region (OR: 0.17; 95% CI: 0.05-0.55; P = 0.002), but not late gadolinium enhancement, were independent predictors of recovered EF. Compared with native T1 value alone, combined native T1 high region and native T1 value improved the area under the curve from 0.703 to 0.788 for predicting recovered EF. Myocardial damage, which was quantified using native T1 mapping and the native T1 high region were independently associated with recovered EF in patients with newly diagnosed DCM.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005682 Gadolinium An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013318 Stroke Volume The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume. Ventricular Ejection Fraction,Ventricular End-Diastolic Volume,Ventricular End-Systolic Volume,Ejection Fraction, Ventricular,Ejection Fractions, Ventricular,End-Diastolic Volume, Ventricular,End-Diastolic Volumes, Ventricular,End-Systolic Volume, Ventricular,End-Systolic Volumes, Ventricular,Fraction, Ventricular Ejection,Fractions, Ventricular Ejection,Stroke Volumes,Ventricular Ejection Fractions,Ventricular End Diastolic Volume,Ventricular End Systolic Volume,Ventricular End-Diastolic Volumes,Ventricular End-Systolic Volumes,Volume, Stroke,Volume, Ventricular End-Diastolic,Volume, Ventricular End-Systolic,Volumes, Stroke,Volumes, Ventricular End-Diastolic,Volumes, Ventricular End-Systolic
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left
D019028 Magnetic Resonance Imaging, Cine A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo MRI sequence with retrospective ECG-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualized. Cine MRI,Cine Magnetic Resonance Imaging,Cine MRIs,MRI, Cine,MRIs, Cine

Related Publications

Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
October 2014, Zhonghua xin xue guan bing za zhi,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
December 2010, The American journal of cardiology,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
August 2021, The international journal of cardiovascular imaging,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
April 2011, Journal of cardiac failure,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
October 2018, Journal of the American Heart Association,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
October 2009, European journal of nuclear medicine and molecular imaging,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
October 2018, Heart and vessels,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
March 2024, Biomedicines,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
June 1991, Clinical nuclear medicine,
Mayu Yazaki, and Takeru Nabeta, and Yu Takigami, and Yuko Eda, and Kenji Maemura, and Takumi Oki, and Teppei Fujita, and Yuichiro Iida, and Yuki Ikeda, and Shunsuke Ishii, and Yusuke Inoue, and Junya Ako
January 2020, Cardiology,
Copied contents to your clipboard!